RBC Capital raised the firm’s price target on Arm (ARM) to $175 from $130 and keeps an Outperform rating on the shares. The firm is citing the company’s much-anticipated full-chip strategy, which the management believes will complement its IP business, the analyst tells investors in a research note. The strategy offers significant revenue growth and earnings potential over the long term but comes with gross margin dilution and channel conflict issues however, the firm added.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARM:
- Arm price target raised to $240 from $201 at Guggenheim
- Arm 2031 outlook beat most bullish expectations, says Citi
- Arm upgraded to Outperform from Market Perform at Raymond James
- Arm price target raised to $140 from $125 at Deutsche Bank
- Arm Reaffirms Q4 2026 Outlook at ‘Arm Everywhere’ Investor Event
